Kicking off #GI26 by addressing a critical gap in care: exocrine pancreatic insufficiency. Together w/ @PanCAN , we’ve developed the 1st US consensus statements for identifying & managing EPI in pancreatic oncology. bit.ly/4svBtV0
1
64
Register now! 1440.zoom.us/webinar/registe… Join @CanopyCancer & @PanCAN TOMORROW, 10/29 @ 2pm ET, to discuss the 1st-ever U.S. consensus statements on Exocrine Pancreatic Insufficiency (EPI) in Pancreatic Cancer Care. All registrants receive a copy of the recording after the event.
1
2
101
1 WEEK LEFT TO REGISTER! (1440.zoom.us/webinar/registe…) for @CanopyCancer & @PanCAN's live Q&A on 10/26 covering the 1st-ever U.S. consensus statements on best practices for #EPI in #PancreaticCancer If you're unable to attend, register! The recording will be sent to all registrants.
38
The 1st U.S. consensus statements on EPI in pancreatic cancer are here! On Oct. 29, hear from these highlighted authors about turning best practices into better patient outcomes, and bring your questions to the live Q&A. Register: 1440.zoom.us/webinar/registe… More speakers in comments
1
1
1
204
Oct 29th EPI White Paper webinar speaker highlights continued!
15
Calling all Healthcare Professionals! Register to join @CanopyCancerC for a Q&A about the 1st U.S. consensus statements on EPI in pancreatic oncology in partnership with @PanCAN October 29, 2026 @ 2-3pm ET / 11-12pm PT Register: 1440.zoom.us/webinar/registe…
1
3
612
🚨 BREAKING: Big milestone in cancer treatment. The FDA has approved daraxonrasib (Rasonque) for advanced pancreatic cancer. #PancreaticCancer #Oncology #FDA #Biotech #Rasonque
48
Check out more incredible findings like these consensus statements in the full white paper on Canopy's Resources page - canopycancer.org/epi-pertwhi…
For people with #pancreaticcancer, recognizing and managing exocrine pancreatic insufficiency (EPI) is an important part of supportive care. @CanopyCancerC and PanCAN developed the first-ever U.S. national consensus statements to help advance awareness, identification and management of EPI and pancreatic enzyme replacement therapy (PERT). Scroll to read Part III of the statements, and visit 🔗 canopycancer.org/epi-pertwhi… to explore the full white paper and recommendations.
1
1
185
More incredible work with our partners at @PanCAN ! Read all about EPI Management in Pancreatic Cancer Care in these first of their kind Consensus Statements here or in the full White Paper at the Canopy website: canopycancer.org/epi-pertwhi…
People with #pancreaticcancer may experience exocrine pancreatic insufficiency (EPI), a condition that can impact nutrition and quality of life. @CanopyCancerC and @PanCAN developed the first-ever U.S. national consensus statements to help guide EPI identification and EPI/pancreatic enzyme replacement therapy (PERT) management. Scroll to read Part II of the statements, and visit 🔗 canopycancer.org/epi-pertwhi… to explore the full white paper and recommendations.
1
11
Canopy Cancer Collective retweeted
Together, @CanopyCancer Collective and @PanCAN developed the first-ever national consensus statements in the U.S. focused on identifying exocrine pancreatic insufficiency (EPI) and guiding EPI/pancreatic enzyme replacement therapy (PERT) management for people with #pancreaticcancer. Read Part I of the statements, and visit 🔗 canopycancer.org/epi-pertwhi… to explore the full white paper and recommendations.
1
5
4
493
Canopy Cancer Collective retweeted
Jessica D. shares, "Year 2 walking for Lolly’s Legacy with PanCAN. 💜 Because of so many of you, we raised $1,711 for pancreatic cancer research and were a Top 10 Team for our South Carolina PurpleStride. Seeing our team name printed on the back of that shirt for the 2nd year makes me so proud! Thank you to every single person who donated, shared and showed up — your support really means a lot to me! Grief looks different every year, but honoring my mom will always be something I show up for." Thank you to Jessica and to all who showed up to walk to end #pancreaticcancer at #PanCANPurpleStride! All together, we can change the story of this disease. 👟🫶 Fundraising for PurpleStride 2026 is still open — there’s still time to support a Strider, team or event at 🔗 purplestride.org.
3
7
259
Innovation at #GI26 wasn't just about drugs but about better care delivery. We’re proud to highlight our work w/ @PanCAN establishing 15 new U.S. consensus statements for managing EPI in pancreatic cancer patients. White Paper ➡️ canopycancer.org/epi-pertwhi…
2
6
399
Canopy Cancer Collective retweeted
We're excited to share insights from a new collaborative White Paper developed by @CanopyCancer Collective, with PanCAN as a lead contributor. The paper presents the first U.S. consensus statements on identifying and managing exocrine pancreatic insufficiency (EPI) in pancreatic cancer care. HCPs attending ASCO #GI26: Download the paper and connect with us at the conference! 🔗 bit.ly/4qsSbTL
1
6
9
602
Canopy Cancer Collective retweeted
We hope you’re able to attend our inspiring virtual event highlighting how you change the story of #pancreaticcancer through our biggest community event of the year: #PanCANPurpleStride! 👟💜 Let’s celebrate the progress you make possible and hear how our mission is truly in motion with updates on PanCAN’s work and stories from Striders like you who are helping drive change. This event is perfect for anyone ready to push our mission forward, so feel free to invite your family and friends. RSVP today for the PanCAN PurpleStride 2026 Kickoff: Mission in Motion on Wednesday, January 28 at 5:00 p.m. PT at 🔗 pcan.at/6ho7k4.
1
6
7
285
Thank for you sharing!
We're excited to share insights from a new collaborative White Paper developed by @CanopyCancer Collective, with PanCAN as a lead contributor. The paper presents the first U.S. consensus statements on identifying and managing exocrine pancreatic insufficiency (EPI) in pancreatic cancer care. HCPs attending ASCO #GI26: Download the paper and connect with us at the conference! 🔗 bit.ly/4qsSbTL
1
16
Canopy’s unique relationships across philanthropy, biotechnology, and leading cancer centers enable us to act as the connective tissue for person-centered pancreatic cancer innovation—translating research into scalable, real-world care improvements.
15